Trial Profile
Efficacy and safety of blonanserin augmentationtherapy for treatment resistance in depression
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 21 Jun 2019
Price :
$35
*
At a glance
- Drugs Blonanserin (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 19 Jun 2019 Status changed from recruiting to completed.
- 15 Dec 2015 New trial record